SCOPUS 정보 검색 플랫폼

Nephrology Dialysis Transplantation

Volumn 17, Issue 6, 2002, Pages 955-957

Cytotoxic therapy of lupus nephritis: Recent developments

(2) Houssiau, Frédéric A a Jadoul, Michel a

a CLINIQUES UNIVERSITAIRES SAINT LUC (Belgium)

Author keywords

Cyclophosphamide; Lupus nephritis

Indexed keywords

AZATHIOPRINE; CREATININE; CYCLOPHOSPHAMIDE; CYTOTOXIC AGENT; GLUCOCORTICOID; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID; ANTINEOPLASTIC AGENT; IMMUNOSUPPRESSIVE AGENT;

CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE SEVERITY; DRUG EFFICACY; DRUG PULSE THERAPY; EDITORIAL; GRAFT REJECTION; HEALTH CARE ORGANIZATION; HERPES ZOSTER; HUMAN; INTERMETHOD COMPARISON; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LUPUS ERYTHEMATOSUS NEPHRITIS; OVARY DISEASE; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; CYCLOPHOSPHAMIDE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUPUS NEPHRITIS;

EID: 0035991910 PISSN: 09310509 EISSN: None Source Type: Journal
DOI: 10.1093/ndt/17.6.955 Document Type: Editorial

Times cited : (12)

References (22)

1
- 0022578857
- Therapy of lupus nephritis
- (1986) N. Engl. J. Med , vol.314 , pp. 614-619
- Austin H.A. III¹ Klippel, J.H.² Balow, J.E.³

2
- 0026767866
- Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis
- (1992) Lancet , vol.340 , pp. 741-745
- Boumpas, D.T.¹ Austin H.A. III² Vaughan, E.M.³

3
- 0030268581
- Methylprednisolone and cyclophosphamide, alone or in combination, in combination, in patients with lupus nephritis
- (1996) Ann. Intern. Med , vol.125 , pp. 549-557
- Gourley, M.F.¹ Austin H.A. III² Scott, D.³

4
- 0035928643
- Combination therapy with pulse cyclophosphamide plus pulse methylprednisolone improves long-term renal outcome without adding toxicity in patients with lupus nephritis
- (2001) Ann. Intern. Med , vol.135 , pp. 248-257
- Illei, G.G.¹ Austin, H.A.² Crane, M.³

5
- 0027450167
- Is 'aggressive' therapy necessary for systemic lupus erythematosus?
- (1993) Rheum. Dis. Clin. North Am , vol.19 , pp. 263-270
- Urowitz, M.B.¹

6
- 0030863877
- Treatment of lupus nephritis-the advantages of a flexible approach
- (1997) Nephrol. Dial. Transplant , vol.12 , pp. 2057-2059
- Ponticelli, C.¹

7
- 0035928689
- The treatment of lupus nephritis: Revisiting Galen
- (2001) Ann. Intern. Med , vol.135 , pp. 296-298
- Lewis, E.J.¹

8
- 0030940420
- Treatment of lupus nephritis: A meta-analysis of clinical trials
- (1997) Am. J. Kidney Dis , vol.29 , pp. 193-199
- Bansal, V.K.¹ Beto, J.A.²

9
- 0027380153
- Risk for sustained amenorrhea in patients with systemic lupus erythematosus receiving intermittent pulse cyclophosphamide therapy
- (1993) Ann. Intern. Med , vol.119 , pp. 366-369
- Boumpas, D.T.¹ Austin H.A. III² Vaughan, E.M.³

10
- 0026257144
- Short course of weekly low-dose intravenous pulse cyclophosphamide in the treatment of lupus nephritis: A preliminary study
- (1991) Lupus , vol.1 , pp. 31-35
- Houssiau, F.A.¹ D'Cruz, D.P.² Haga, H.-J.³

11
- 0035170339
- Update on the European Vasculitis Study Group trials
- on behalf of the European Vasculitis Study Group (EUVAS)
- (2001) Curr. Opin. Rheumatol , vol.13 , pp. 48-55
- Jayne, D.¹

12
- 0030988591
- Immunosuppressive therapy in lupus nephritis
- (1997) Clin. Exp. Rheumatol , vol.15 , pp. 275-282
- D'Cruz, D.¹ Cuadrado, M.J.² Mujic, F.³

13
- 0026638959
- Short term effects of intravenous pulses of cyclophosphamide in the treatment of connective tissue disease crisis
- (1992) Ann. Rheum. Dis , vol.51 , pp. 885-888
- Haga, H.-J.¹ D'Cruz, D.² Asherson, R.³

14
- 0009700129
- Immunosuppressive therapy in lupus nephritis: A randomized trial of low-dose versus high-dose intravenous cyclophosphamide. The Euro-lupus Nephritis Trial
- (in press)
- (2002) Arthritis Rheum
- Houssiau, F.A.¹ Vasconcelos, C.² D'Cruz, D.³

15
- 0034877991
- The evidence base for the treatment of lupus nephritis in the new millennium
- (2001) Nephrol. Dial. Transplant , vol.16 , pp. 1538-1636
- Adu, D.¹

16
- 0032729298
- Mycophenolate mofetil. A review of its use in the management of solid organ transplantation
- (1999) Biodrugs , vol.12 , pp. 363-410
- Bardsley-Elliot, A.¹ Noble, S.² Foster, R.H.³

17
- 0029006409
- Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection
- European Mycophenolate Mofetil Cooperative Study Group
- (1995) Lancet , vol.345 , pp. 1321-1325

18
- 20244388105
- A randomized active-controlled trial of mycophenolate mofetil in heart transplant recipients. Mycophenolate Mofetil Investigators
- (1998) Transplantation , vol.66 , pp. 507-515
- Kobashigawa, J.¹ Miller, L.² Renlund, D.³

19
- 0034687429
- for the Hong Kong-Guangzhou Nephrology Study Group
- (2000) N. Engl. J. Med , vol.343 , pp. 1156-1162
- Chan, T.M.¹ Li, F.K.² Tang, C.S.O.³

20
- 0032535657
- Immunoablative high-dose cyclophosphamide without stem-cell rescue for refractory, severe autoimmune disease
- (1998) Ann. Intern. Med , vol.129 , pp. 1031-1035
- Brodsky, R.A.¹ Petri, M.² Douglas Smith, B.³

21
- 0033883903
- Clinical and biologic effects of anti-interleukin-10 monoclonal antibody administration in systemic lupus erythematosus
- (2000) Arthritis Rheum , vol.43 , pp. 1790-1800
- Llorente, L.¹ Richaud-Patin, Y.² Garcia-Padilla, C.³

22
- 0035163042
- Phase I clinical trial of a monoclonal antibody against CD40-ligand (IDEC-131) in patients with systemic lupus erythematosus
- (2001) J. Rheumatol , vol.28 , pp. 95-101
- Davis J.C., Jr.¹ Tortoritis, M.C.² Rosenberg, J.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.